{"id":168601,"date":"2025-06-02T06:33:08","date_gmt":"2025-06-02T10:33:08","guid":{"rendered":"https:\/\/44.250.171.167\/?p=168601"},"modified":"2025-06-02T06:33:08","modified_gmt":"2025-06-02T10:33:08","slug":"abbott-india-ltd-q4fy25-87-rise-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/abbott-india-ltd-q4fy25-87-rise-in-profits\/","title":{"rendered":"Abbott India Ltd Q4FY25; 87% rise in Profits"},"content":{"rendered":"<p>Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944.<\/p>\n<p>Financial Results:<\/p>\n<p>Abbott India Ltd reported Revenues for Q4FY25 of \u20b96,375.00 Crores up from \u20b94,707.00 Crore year on year, a rise of 35.44%.<\/p>\n<p>Total Expenses for Q4FY25 of \u20b95,623.00 Crores up from \u20b94,359.00 Crores year on year, a rise of 29.0%.<\/p>\n<p>Consolidated Net Profit of \u20b9714.00 Crores up 87.4% from \u20b9381.00 Crores in the same quarter of the previous year.<\/p>\n<p>The Earnings per Share is \u20b95.39, up 66.36% from \u20b93.24 in the same quarter of the previous year.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-168602\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png\" alt=\"\" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abbott India Ltd is one of the leading multinational pharmaceutical companies in India and sells its products through independent distributors primarily within India. It was established in 1944. Financial Results: Abbott India Ltd reported Revenues for Q4FY25 of \u20b96,375.00 Crores up from \u20b94,707.00 Crore year on year, a rise of 35.44%. Total Expenses for Q4FY25 [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":168602,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[10162],"class_list":["post-168601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":168730,"url":"https:\/\/alphastreet.com\/india\/astrazeneca-pharma-india-ltd-q4fy25-3-rise-in-revenue\/","url_meta":{"origin":168601,"position":0},"title":"Astrazeneca Pharma India Ltd Q4FY25; 3% rise in Revenue","author":"Divyansh_Kasana","date":"June 10, 2025","format":false,"excerpt":"AstraZeneca Pharma India Ltd is engaged in the business of manufacture, distribution and marketing of pharmaceutical products. Financial Results: Astrazeneca Pharma India Ltd reported Revenues for Q4FY25 of \u20b91,000.00 Crores up from \u20b9974.00 Crore year on year, a rise of 2.67%. Total Expenses for Q4FY25 of \u20b9914.00 Crores up from\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/U-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169044,"url":"https:\/\/alphastreet.com\/india\/dr-reddys-laboratories-ltd-q4fy25-21-rise-in-profits\/","url_meta":{"origin":168601,"position":1},"title":"Dr Reddys Laboratories Ltd Q4FY25; 21% rise in Profits","author":"Divyansh_Kasana","date":"July 8, 2025","format":false,"excerpt":"Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations. Financial Results: Dr Reddys Laboratories Ltd reported Revenues for Q4FY25 of \u20b98,528.00 Crores up from \u20b97,114.00 Crore year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/O-4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169071,"url":"https:\/\/alphastreet.com\/india\/emcure-pharmaceuticals-ltd-q4fy25-63-rise-in-profits\/","url_meta":{"origin":168601,"position":2},"title":"Emcure Pharmaceuticals Ltd Q4FY25; 63% rise in Profits","author":"Divyansh_Kasana","date":"July 9, 2025","format":false,"excerpt":"Incorporated in 1981, Emcure Pharmaceuticals Ltd manufactures and markets pharmaceutical products globally Financial Results: Emcure Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b92,116.00 Crores up from \u20b91,771.00 Crore year on year, a rise of 19.48%. Total Expenses for Q4FY25 of \u20b91,850.00 Crores up from \u20b91,616.00 Crores year on year, a\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-5.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-5.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-5.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-5.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-5.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/I-5.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169080,"url":"https:\/\/alphastreet.com\/india\/eris-lifesciences-ltd-q4fy25-28-rise-in-profits\/","url_meta":{"origin":168601,"position":3},"title":"ERIS Lifesciences Ltd Q4FY25; 28% rise in Profits","author":"Divyansh_Kasana","date":"July 10, 2025","format":false,"excerpt":"ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products. Financial Results: ERIS Lifesciences Ltd reported Revenues for Q4FY25 of \u20b9705.00 Crores up from \u20b9551.00 Crore year on year, a rise of 27.95%. Total Expenses for Q4FY25 of \u20b9584.00 Crores up from \u20b9489.00 Crores year\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/07\/L-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168663,"url":"https:\/\/alphastreet.com\/india\/alkem-laboratories-ltd-q4fy25-6-rise-in-profits\/","url_meta":{"origin":168601,"position":4},"title":"Alkem Laboratories Ltd Q4FY25; 6% rise in Profits","author":"Divyansh_Kasana","date":"June 5, 2025","format":false,"excerpt":"Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107) Financial Results: Alkem Laboratories Ltd reported Revenues for Q4FY25 of \u20b93,144.00 Crores up from \u20b92,936.00 Crore year on year,\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/06\/I-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168473,"url":"https:\/\/alphastreet.com\/india\/torrent-pharmaceuticals-ltd-q4fy25-11-rise-in-profits\/","url_meta":{"origin":168601,"position":5},"title":"Torrent Pharmaceuticals Ltd Q4FY25; 11% rise in Profits","author":"Chirag Gupta","date":"May 21, 2025","format":false,"excerpt":"Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. Financial Results: Torrent Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b92,959.00 Crores up from \u20b92,745.00 Crore year on year, a rise of 7.8%. Total Expenses for Q4FY25 of\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/2-11.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/2-11.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/2-11.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/2-11.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/2-11.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/2-11.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=168601"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/168601\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/168602"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=168601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=168601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=168601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}